Why is Pfizer important to traders?
One of the world’s largest pharmaceutical companies, Pfizer develops and manufactures medicines and healthcare products that help patients across numerous important therapeutic sectors, including Oncology, Vaccines, Inflammation & Immunology, Rare Disease and Internal Medicine.
According to the company’s website, Pfizer’s products are the results of the work of 1,500 scientists conducting and overseeing over 500,000 laboratory tests and more than 36 clinical trials before the first prescription. As of February 2021, Pfizer worked on 95 discovery projects on different stages of clinical trials.
The list of Pfizer’s most popular medicines include Lyrica (Pregabalin) for fibromyalgia and neuropathic pain; Lipitor (atorvastatin) for lowering blood cholesterol; Zithromax (azithromycin), an antibiotic; Diflucan (fluconazole), an oral antifungal medicine; Celebrex (celecoxib), an anti-inflammatory medicine; Prevnar 13, a pneumococcal vaccine; and Viagra (sildenafil) for erectile dysfunction.
In 2020, Pfizer hit the headlines with the positive news on the 95 per cent efficacy of its Covid-19 vaccine. In December 2020, Pfizer-BioNTech’s vaccine, called BNT162b2, became the first candidate approved for use in the United Kingdom and the USA.
Pfizer stock is traded on the New York stock exchange under the ticker symbol PFE. The stock is a component of the S&P 100 and the S&P 500 stock market indices. It was also a part of the Dow Jones Industrial Average until August 2020.
Trade Pfizer Inc - PFE CFD
Pfiser stock trading hours
If you choose to trade CFDs, you can follow the Pfizer (PFE) stock performance live in US dollars with the comprehensive Pfizer share price graph at Capital.com:
Monday to Friday from 14:30 to 21:00.
This gives you plenty of time to monitor the company’s activity and keep an eye out for any events that may affect short-term movements in the Pfizer share value.
How to trade Pfizer shares with CFDs
An individual has two options when trading in the stock market. Firstly, they can buy shares in companies on the exchanges where they are listed. For instance, investing in Pfizer stock on the NYSE you actually acquire a share in the company. This can be considered a long-term investment, as the individual is usually waiting for the price to rise over time.
Alternatively, they can trade a contract for difference (CFD) for the Pfizer stock market price, and speculate on its difference without actually owning the asset. A CFD is a financial contract, typically between a broker and an investor, where one party agrees to pay the other the difference in the value of a security, between the opening and closing of the trade.
You can either hold a long position (speculating that the price will rise) or a short position (speculating that the price will fall). This is considered a short-term investment or trade, as CFDs tend to be used within shorter timeframes.
The key difference between Pfizer share trading through a long position with a CFD and buying a security is the leverage that is employed. CFDs are traded on margin, which means that a trader can open larger positions with their capital.
You can trade Pfizer stock with CFDs right now. Just sign up at Capital.com and use our advanced web platform or download the best-in-class investment app to trade on the go. It will take you just 3 minutes to get started and access the world’s most traded markets.
Why trade Pfizer CFDs with Capital.com?
Advanced AI technology at its core: a Facebook-like News Feed provides users with personalised and unique content depending on their preferences. If a trader makes decisions based on biases, the innovative News Feed offers a range of materials to put them back on the right track. The neural network analyses in-app behaviour and recommends videos, articles and news to polish your investment strategy.
Trading on margin: providing trading on margin (up to 5:1 for individual equities), Capital.com gives you access to the Pfizer shares trading with the help of CFDs.
Trading the difference: when you invest in Pfizer shares with CFDs, you don’t buy the underlying asset itself, meaning you are not tied to it. You only speculate on the rise or fall of the PFE performance. CFD trading is nothing different from traditional trading in terms of strategies. A CFD investor can go short or long, set stop and limit losses and apply trading scenarios that align with their objectives.
All-round trading analysis: the browser-based platform allows traders to shape their own market analysis and forecasts with sleek technical indicators. Capital.com provides live market updates and various chart formats, available on desktop, iOS, and Android.
Focus on safety: Capital.com puts a special emphasis on safety. Licensed by the FCA and CySEC, it complies with all regulations and ensures that its clients’ data security comes first. The company allows you to withdraw money 24/7 and keeps traders’ funds across segregated bank accounts.
Pfizer share price history
Founded in 1849, Pfizer is a notorious player on the US stock market. One of the leading pharmaceutical companies in the world, it was ranked 64th in the Fortune 500 list of the largest US corporations by total revenue in 2020.
In 2020, Pfizer was among the first pharma companies who got involved in the Covid vaccine race, aiming to stop the disease. In partnership with Germany's BioNTech, they co-developed a 95 per cent effective mRNA-based vaccine, which later became the first officially approved vaccine in several countries, including the UK and the US.
Pfizer's vaccine rollout was in full swing by the end of 2020. According to the company’s earnings report, it contributed to $154 million in sales in the fourth quarter of 2020.
The positive vaccine news kept the PFE stock moving higher after the sharp sell-off in March. In 2020 the Pfizer stock fluctuated within a range of $27-$43, and ended the year on a positive note.
According to the company’s full-year 2020 report, Pfizer’s total revenue rose two per cent to $41.9 billion, beating analysts’ forecasts and providing an upbeat full-year outlook. In the one year period, the company came to a net income of $594 million, or 10 cents per share, from a net loss of $337 million, or 6 cents per share.
Providing its guidance for 2021, Pfizer expects revenue of $59.4-61.4 billion and the earnings per share of $3.10-3.20.
With Capital.com’s streaming Pfizer stock chart, you can quickly view the price of PFE stock in real time and trace the best levels to open a profitable CFD trade.
Among Pfizer’s major competitors we can define the following brands:
AstraZeneca is a British-Swedish international biopharmaceutical company, headquartered in Cambridge. The company has a portfolio of treatments of major diseases, including cancer, gastrointestinal, cardio, infection, respiratory and other areas. The company has developed its own vaccine against Covid-19, which is now being tested and widely discussed in the media.
Moderna is a US-based clinical-stage biotechnology company, specialising in drug research and development, as well as vaccine technologies based on messenger RNA (mRNA). The company’s Covid-19 vaccine candidate, mRNA-1273, showed an efficacy of 94 per cent during the Phase 3 clinical studies.
Gilead Sciences is an American biopharmaceutical company. Its portfolio includes medicines for HIV prevention and treatment. It also produces medical products serving to cure cardiovascular, oncological and other severe diseases. Today, the company is well-known as the producer of antiviral drug Remdesivir, used as a treatment for Covid-19. However, it was found inefficient according to the recent study by the WHO.
Merck & Co. is an international healthcare company with operations spanning around 140 countries. In the USA and Canada, the company is referred to as Merck, whereas elsewhere it is known under the brand MSD.
One of the world’s largest pharmaceutical companies, Merck is focused on diabetes treatments; hepatitis C, HIV and other infectious diseases treatment; antimicrobial resistance methods; oncology; vaccines; women’s health and cardiovascular diseases.
As with any equity, quarterly earnings announcements and the financial performance of the wider stock market are two crucial factors to watch when deciding how Pfizer stock will perform.
Commenting on the company’s performance in 2020, Dr. Albert Bourla, chairman and chief executive officer, stated: “2020 has been a transformational year, not only for Pfizer, but also in the life of every patient in every community that we serve. As a company, we saw the culmination of Pfizer’s decade-long conversion into a pure-play, science and innovation-focused company. Right away, our ability to move quickly and utilise cutting-edge science to help address the world’s most important medical challenges was put to the test by the Covid-19 pandemic. Our record-breaking success at developing a vaccine against Covid-19, along with our partner BioNTech, is just one example of what we believe this new Pfizer is capable of achieving. As the world looks forward to 2021 with renewed hope for better days ahead, we also look forward with renewed confidence and resolve in our ability to fulfill our purpose, to deliver breakthroughs that change patients’ lives.”
Revenue: For the full year 2020, revenue was $41.9bn, compared to $41,172bn in 2019.
Earnings per share: for the full year 2020 reported diluted EPS was $1.71, adjusted diluted EPS was $2.22, compared to $2.87 and $1.91 respectively in 2019.